Differential targeting of stem cells and differentiated glioblastomas by NK cells

Han Ching Tseng, Akihito Inagaki, Vickie T. Bui, Nicholas Cacalano, Noriyuki Kasahara, Yan Gao Man, Anahid Jewett

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

We have recently shown that Natural Killer (NK) cells control survival and differentiation of Cancer Stem-like Cells (CSCs) through two distinct phenotypes of cytotoxic and anergic NK cells, respectively. In this report, brain CSCs and their serum and NK cell differentiated counterparts were studied. Serum-differentiated brain CSCs were significantly less susceptible to NK cells and CTL direct cytotoxicity as well as NK cell mediated Antibody Dependent Cellular Cytotoxicity (ADCC), whereas their CSCs were highly susceptible. The levels of CD44 and EGFR were higher in brain tumor CSCs when compared to the serum-differentiated tumors. No differences could be observed for the expression of MHC class I between brain tumor stem cells and their serum- differentiated counterparts. Moreover, supernatants from the combination of IL-2 and anti- CD16mAb treated NK cells (anergized NK cells) induced resistance of brain tumor CSCs to NK cell mediated cytotoxicity. Unlike serum-differentiated CSCs, NK supernatant induced differentiation and resistance to cytotoxicity in brain CSCs correlated with the increased expression of CD54 and MHC class I. The addition of anti-MHC class I antibody moderately inhibited NK mediated cytotoxicity against untreated or serum-differentiated CSCs, whereas it increased cytotoxicity against NK supernatant differentiated tumors. Therefore, two distinct mechanisms govern serum and NK supernatant mediated differentiation of brain tumors.

Original languageEnglish (US)
Pages (from-to)866-876
Number of pages11
JournalJournal of Cancer
Volume6
Issue number9
DOIs
StatePublished - 2015

Fingerprint

Neoplastic Stem Cells
Glioblastoma
Natural Killer Cells
Stem Cells
Brain Neoplasms
Serum
Brain Stem
Immunoglobulin Isotypes
Interleukin-2
Cell Differentiation
Neoplasms
Cell Survival

Keywords

  • Brain stem cells
  • GBMs
  • IFN-γ
  • NK

ASJC Scopus subject areas

  • Oncology

Cite this

Tseng, H. C., Inagaki, A., Bui, V. T., Cacalano, N., Kasahara, N., Man, Y. G., & Jewett, A. (2015). Differential targeting of stem cells and differentiated glioblastomas by NK cells. Journal of Cancer, 6(9), 866-876. https://doi.org/10.7150/jca.11527

Differential targeting of stem cells and differentiated glioblastomas by NK cells. / Tseng, Han Ching; Inagaki, Akihito; Bui, Vickie T.; Cacalano, Nicholas; Kasahara, Noriyuki; Man, Yan Gao; Jewett, Anahid.

In: Journal of Cancer, Vol. 6, No. 9, 2015, p. 866-876.

Research output: Contribution to journalArticle

Tseng, HC, Inagaki, A, Bui, VT, Cacalano, N, Kasahara, N, Man, YG & Jewett, A 2015, 'Differential targeting of stem cells and differentiated glioblastomas by NK cells', Journal of Cancer, vol. 6, no. 9, pp. 866-876. https://doi.org/10.7150/jca.11527
Tseng, Han Ching ; Inagaki, Akihito ; Bui, Vickie T. ; Cacalano, Nicholas ; Kasahara, Noriyuki ; Man, Yan Gao ; Jewett, Anahid. / Differential targeting of stem cells and differentiated glioblastomas by NK cells. In: Journal of Cancer. 2015 ; Vol. 6, No. 9. pp. 866-876.
@article{40075537f83c4a03b0598cb1c7cb455f,
title = "Differential targeting of stem cells and differentiated glioblastomas by NK cells",
abstract = "We have recently shown that Natural Killer (NK) cells control survival and differentiation of Cancer Stem-like Cells (CSCs) through two distinct phenotypes of cytotoxic and anergic NK cells, respectively. In this report, brain CSCs and their serum and NK cell differentiated counterparts were studied. Serum-differentiated brain CSCs were significantly less susceptible to NK cells and CTL direct cytotoxicity as well as NK cell mediated Antibody Dependent Cellular Cytotoxicity (ADCC), whereas their CSCs were highly susceptible. The levels of CD44 and EGFR were higher in brain tumor CSCs when compared to the serum-differentiated tumors. No differences could be observed for the expression of MHC class I between brain tumor stem cells and their serum- differentiated counterparts. Moreover, supernatants from the combination of IL-2 and anti- CD16mAb treated NK cells (anergized NK cells) induced resistance of brain tumor CSCs to NK cell mediated cytotoxicity. Unlike serum-differentiated CSCs, NK supernatant induced differentiation and resistance to cytotoxicity in brain CSCs correlated with the increased expression of CD54 and MHC class I. The addition of anti-MHC class I antibody moderately inhibited NK mediated cytotoxicity against untreated or serum-differentiated CSCs, whereas it increased cytotoxicity against NK supernatant differentiated tumors. Therefore, two distinct mechanisms govern serum and NK supernatant mediated differentiation of brain tumors.",
keywords = "Brain stem cells, GBMs, IFN-γ, NK",
author = "Tseng, {Han Ching} and Akihito Inagaki and Bui, {Vickie T.} and Nicholas Cacalano and Noriyuki Kasahara and Man, {Yan Gao} and Anahid Jewett",
year = "2015",
doi = "10.7150/jca.11527",
language = "English (US)",
volume = "6",
pages = "866--876",
journal = "Journal of Cancer",
issn = "1837-9664",
publisher = "Ivyspring International Publisher",
number = "9",

}

TY - JOUR

T1 - Differential targeting of stem cells and differentiated glioblastomas by NK cells

AU - Tseng, Han Ching

AU - Inagaki, Akihito

AU - Bui, Vickie T.

AU - Cacalano, Nicholas

AU - Kasahara, Noriyuki

AU - Man, Yan Gao

AU - Jewett, Anahid

PY - 2015

Y1 - 2015

N2 - We have recently shown that Natural Killer (NK) cells control survival and differentiation of Cancer Stem-like Cells (CSCs) through two distinct phenotypes of cytotoxic and anergic NK cells, respectively. In this report, brain CSCs and their serum and NK cell differentiated counterparts were studied. Serum-differentiated brain CSCs were significantly less susceptible to NK cells and CTL direct cytotoxicity as well as NK cell mediated Antibody Dependent Cellular Cytotoxicity (ADCC), whereas their CSCs were highly susceptible. The levels of CD44 and EGFR were higher in brain tumor CSCs when compared to the serum-differentiated tumors. No differences could be observed for the expression of MHC class I between brain tumor stem cells and their serum- differentiated counterparts. Moreover, supernatants from the combination of IL-2 and anti- CD16mAb treated NK cells (anergized NK cells) induced resistance of brain tumor CSCs to NK cell mediated cytotoxicity. Unlike serum-differentiated CSCs, NK supernatant induced differentiation and resistance to cytotoxicity in brain CSCs correlated with the increased expression of CD54 and MHC class I. The addition of anti-MHC class I antibody moderately inhibited NK mediated cytotoxicity against untreated or serum-differentiated CSCs, whereas it increased cytotoxicity against NK supernatant differentiated tumors. Therefore, two distinct mechanisms govern serum and NK supernatant mediated differentiation of brain tumors.

AB - We have recently shown that Natural Killer (NK) cells control survival and differentiation of Cancer Stem-like Cells (CSCs) through two distinct phenotypes of cytotoxic and anergic NK cells, respectively. In this report, brain CSCs and their serum and NK cell differentiated counterparts were studied. Serum-differentiated brain CSCs were significantly less susceptible to NK cells and CTL direct cytotoxicity as well as NK cell mediated Antibody Dependent Cellular Cytotoxicity (ADCC), whereas their CSCs were highly susceptible. The levels of CD44 and EGFR were higher in brain tumor CSCs when compared to the serum-differentiated tumors. No differences could be observed for the expression of MHC class I between brain tumor stem cells and their serum- differentiated counterparts. Moreover, supernatants from the combination of IL-2 and anti- CD16mAb treated NK cells (anergized NK cells) induced resistance of brain tumor CSCs to NK cell mediated cytotoxicity. Unlike serum-differentiated CSCs, NK supernatant induced differentiation and resistance to cytotoxicity in brain CSCs correlated with the increased expression of CD54 and MHC class I. The addition of anti-MHC class I antibody moderately inhibited NK mediated cytotoxicity against untreated or serum-differentiated CSCs, whereas it increased cytotoxicity against NK supernatant differentiated tumors. Therefore, two distinct mechanisms govern serum and NK supernatant mediated differentiation of brain tumors.

KW - Brain stem cells

KW - GBMs

KW - IFN-γ

KW - NK

UR - http://www.scopus.com/inward/record.url?scp=84947743283&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84947743283&partnerID=8YFLogxK

U2 - 10.7150/jca.11527

DO - 10.7150/jca.11527

M3 - Article

AN - SCOPUS:84947743283

VL - 6

SP - 866

EP - 876

JO - Journal of Cancer

JF - Journal of Cancer

SN - 1837-9664

IS - 9

ER -